Since then, a number of triple agonists have entered clinical development, with one in phase three clinical studies but have yet to reach the market (Capozzi, DiMarchi, Tschp)
Other GLP-1R agonists have demonstrated extensive pleiotropic effects, including benefits in managing comorbidities such as osteoarthritis, cardiovascular disease, and neurodegenerative disorders
GLP-1 Patches Side Effects & Safety According to research by pharmacology experts at the University of Connecticut, consumers have reported experiencing skin rashes, burns, and blisters from using these patches
What Reddit's GLP-1 Communities Are Saying About Food From cravings to avoidance, here's what thousands of GLP-1 users are saying about how their relationship with food has changed
Wegovy | European Medicines Agency (EMA)
Announcement: American Medical Association